longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Cytek Biosciences

CTKB

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -9.21, within the reasonable range, cheaper than 26.04% of the time in the past 5 years, and the industry ranks 41/59, the industry Median -1.52.

-9.21xP/E
$5.71Stock price
$-0.62Earnings per share
-9.21xP/E
Stock price$5.71Earnings per share$-0.62

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-67.17x
Typical range
-388.08x–-7.71x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
LZAGYUSLonza
-347.83x--$47.93B
TEMUSTempus AI
-54.43x1.23%$13.85B
CRLUSCharles River Laboratorie
-57.08x225.72%$13.61B
TXGUS10X Genomics
-139.96x107.32%$10.51B
AVTRUSAvantor
-17.48x142.83%$10.10B
BRKRUSBruker
-87.24x7.71%$9.33B
ADPTUSAdaptive Biotechnologies
-70.13x39.98%$4.48B
ABCLUSAbcellera Biologics
-24.90x34.69%$4.10B
ALMRUSAlamar Biosciences
-46.42x80.55%$2.31B
FTREUSFortrea
-22.80x93.77%$1.94B
MRVIUSMaravai LifeSciences
-25.03x65.83%$1.94B
PSNLUSPersonalis
-16.30x20.05%$1.75B
AZTAUSAzenta
-12.22x180.77%$1.50B
CYRXUSCryoport
-19.61x156.25%$889.90M
CTKBUSCytek Biosciences
-9.21x33.98%$742.20M
OABIUSOmniAb
-16.16x35.96%$715.32M
DNAUSGinkgo Bioworks
-2.17x35.20%$630.98M
EVOUSEvotec SE
-2.45x390.22%$561.23M
TKNOUSAlpha Teknova
-28.08x5.80%$470.85M
PACBUSPacific Biosc California
-3.48x75.82%$456.92M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.